SG Americas Securities, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 96 filers reported holding RAPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.5%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$240
-99.8%
13,058
+105.6%
0.00%
+50.0%
Q3 2022$153,000
+4.8%
6,351
+59.5%
0.00%
+100.0%
Q4 2021$146,000
-97.1%
3,982
-97.5%
0.00%
-95.7%
Q3 2021$4,976,000
+112.2%
160,250
+117.2%
0.02%
+109.1%
Q2 2021$2,345,000
+1263.4%
73,766
+1142.5%
0.01%
+1000.0%
Q2 2020$172,0005,9370.00%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders